Market Analysis and Price Projections for the Drug NDC: 49348-0872
Introduction
The National Drug Code (NDC) 49348-0872 corresponds to the drug Sunmark Miconazole 7, an antifungal medication. To conduct a comprehensive market analysis and price projection for this drug, we need to consider several factors, including current pricing, market trends, regulatory environments, and competitor analysis.
Understanding the NDC
The NDC 49348-0872 is assigned to Sunmark Miconazole 7, which is manufactured and distributed by Strategic Sourcing Services LLC. The NDC directory maintained by the FDA contains detailed information about this drug, including its marketing start and end dates, and any changes in its status[4].
Current Pricing
As of the latest available data, the pricing for Sunmark Miconazole 7 is not explicitly provided in the sources. However, we can infer pricing trends from similar antifungal medications and the broader pharmaceutical market.
For example, the prices of other medications can give us a benchmark. The price of Dapsone 5% Gel, another topical medication, has been tracked and shows variations based on the unit size and vendor. For instance, the price per unit of Dapsone 5% Gel can range from $1.37 to $1.87 depending on the quantity and vendor[2].
Market Trends
The pharmaceutical market, particularly in the U.S., has seen significant price increases over the past few years. According to an ASPE issue brief, the average price per unit in the U.S. has increased by 14% between 2017 and 2022, which is significantly higher than in other OECD countries and the rest of the world[3].
Global Comparison
The U.S. pharmaceutical market stands out with prices that are 5.5 times higher than those in the OECD (excluding the U.S.) and 7.7 times higher than in the rest of the world. This disparity suggests that any price projections for Sunmark Miconazole 7 in the U.S. market should account for these higher price levels[3].
Regulatory Environment
The pricing of Sunmark Miconazole 7 is influenced by regulatory requirements, particularly those related to the Medicaid Drug Rebate Program (MDRP). Manufacturers participating in this program must adhere to the statutory pricing formula, which involves calculating the 340B ceiling price by subtracting the Unit Rebate Amount (URA) from the Average Manufacturer Price (AMP) for the smallest unit of measure[5].
340B Ceiling Price
For drugs like Sunmark Miconazole 7, the 340B ceiling price is crucial for sales to covered entities. This price is calculated based on the AMP and URA, and it must be adjusted for the package size and case pack size to ensure compliance with regulatory requirements[5].
Competitor Analysis
The antifungal market is competitive, with several brands and generic options available. Sunmark, being a generic brand, competes with other generic and brand-name antifungals. The pricing strategy for Sunmark Miconazole 7 would need to consider the prices of these competitors to remain competitive.
Generic vs. Brand-Name
Generic drugs like Sunmark Miconazole 7 generally have lower prices compared to their brand-name counterparts. However, the pricing difference can vary based on market conditions and the specific competition in the antifungal segment.
Price Projections
Given the current market trends and regulatory environment, here are some key points to consider for price projections:
- Historical Pricing Trends: Prices in the U.S. pharmaceutical market have been increasing, so it is likely that Sunmark Miconazole 7 will see some price increase.
- Regulatory Compliance: The 340B ceiling price calculations will play a significant role in determining the minimum price at which the drug can be sold to covered entities.
- Competitive Landscape: The drug's price will need to be competitive with other antifungal medications in the market.
Potential Price Range
While exact price projections are not available without current pricing data, we can estimate that the price per unit of Sunmark Miconazole 7 will likely fall within a range similar to other generic antifungal medications. For example, if similar medications are priced between $1 to $3 per unit, Sunmark Miconazole 7 could be expected to fall within this range, adjusted for its specific market conditions.
Conclusion
The market analysis and price projections for Sunmark Miconazole 7 (NDC: 49348-0872) must consider the broader pharmaceutical market trends, regulatory requirements, and the competitive landscape. Given the historical price increases in the U.S. market and the need for regulatory compliance, it is reasonable to expect that the price of this drug will remain competitive but may see some increase over time.
Key Takeaways
- Market Trends: The U.S. pharmaceutical market has seen significant price increases.
- Regulatory Environment: Compliance with the Medicaid Drug Rebate Program and 340B ceiling price calculations is crucial.
- Competitor Analysis: The drug competes in a competitive antifungal market.
- Price Projections: Prices are likely to remain competitive but may increase based on market trends.
FAQs
What is the NDC 49348-0872?
The NDC 49348-0872 corresponds to Sunmark Miconazole 7, an antifungal medication.
Who manufactures Sunmark Miconazole 7?
Sunmark Miconazole 7 is manufactured and distributed by Strategic Sourcing Services LLC.
How are prices for Sunmark Miconazole 7 determined?
Prices are determined based on the Average Manufacturer Price (AMP) and Unit Rebate Amount (URA) for compliance with the Medicaid Drug Rebate Program.
Why are pharmaceutical prices in the U.S. higher than in other countries?
Pharmaceutical prices in the U.S. are higher due to various factors, including regulatory differences, market dynamics, and the drug mix in the U.S. market.
What is the 340B ceiling price, and how is it calculated?
The 340B ceiling price is calculated by subtracting the Unit Rebate Amount (URA) from the Average Manufacturer Price (AMP) for the smallest unit of measure, then adjusted for package size and case pack size.
Sources
- Find-A-Code: McKesson - List of Drugs - NDC Labeler/Manufacturer.
- DrugPatentWatch: Latest drug prices and trends for NDC 51672-1387.
- ASPE: ISSUE BRIEF - International Market Size and Prices.
- FDA: National Drug Code Directory.
- HRSA: NDC Product Details - Log into 340B OPAIS.
